Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

2.55USD
13 Dec 2017
Change (% chg)

$0.05 (+2.00%)
Prev Close
$2.50
Open
$2.45
Day's High
$2.55
Day's Low
$2.45
Volume
6,598
Avg. Vol
11,216
52-wk High
$9.90
52-wk Low
$2.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.26 -0.430
Jun '17 0.01 -0.410
Mar '17 0.02 -0.419
FY 2016 Dec '16 0.38 -0.335
Sep '16 0.41 -0.505
Jun '16 0.41 -0.418
Mar '16 0.60 -0.227
FY 2015 Dec '15 3.23 -0.274
Sep '15 4.29 -0.268
Jun '15 4.05 0.077
Mar '15 4.01 -0.644
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 6.38 12.50 0.25 --
Year Ending Dec-17 3 4.55 12.80 0.30 19.87
Year Ending Dec-18 3 5.17 13.50 0.00 20.63
Earnings (per share)
Quarter Ending Dec-17 2 -0.11 0.22 -0.44 --
Year Ending Dec-17 3 -1.49 -1.01 -1.75 -0.90
Year Ending Dec-18 3 -1.67 -1.07 -2.00 -1.14
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. 21.51 290.75 45.62
P/E Low - Last 5 Yrs. 21.51 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 65.85 100.67 5.40
Price to Book (MRQ) 1.07 13.50 5.38
Price to Tangible Book (MRQ) 1.07 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 63.38 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -96.37 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -90.39 75.03 5.38
Sales - 5 Yr. Growth Rate -23.58 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.79 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -40.79 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -0.77 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 13.95 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -9.68 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -3,415.37 -- --
EBITD - 5 Yr. Avg -14.16 -261.11 15.24
Operating Margin (TTM) -3,496.71 -556.64 7.76
Operating Margin - 5 Yr. Avg. -18.89 -279.29 10.75
Pre-Tax Margin (TTM) -3,489.63 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -20.59 -279.02 11.17
Net Profit Margin (TTM) -3,489.63 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -20.59 -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 9,318 25,314,503 864,673,362
Net Income/Employee (TTM) -325,170 3,332,048 101,717,513
Receivable Turnover (TTM) 1.92 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.01 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.07 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -55.45 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -55.50 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -88.43 -59.61 -23.58
EPS (TTM) % -34.58 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Xenon Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.06%
# of Holders: 35
Total Shares Held: 11,349,219
3 Mo. Net Change: -103,280
# New Positions: 2
# Closed Positions: 10
# Increased Positions: 11
# Reduced Positions: 16
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.